Free Trial
NASDAQ:MTEX

Mannatech Q2 2024 Earnings Report

Mannatech logo
$8.47 -0.09 (-1.05%)
As of 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mannatech EPS Results

Actual EPS
-$0.33
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mannatech Revenue Results

Actual Revenue
$27.74 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mannatech Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
5:00PM ET

Upcoming Earnings

Mannatech's Q3 2025 earnings is scheduled for Tuesday, November 11, 2025

Mannatech Earnings Headlines

Mannatech Extends Loan Repayment to March 2027
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel
Mannatech, Incorporated (MTEX) - Yahoo Finance
See More Mannatech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mannatech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mannatech and other key companies, straight to your email.

About Mannatech

Mannatech (NASDAQ:MTEX), Inc. is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality. Among its most recognized products is Ambrotose®, a patented blend of plant-derived saccharides. Mannatech has also expanded into targeted formulations for children’s health, weight management, and topical therapies, leveraging its nutrition science platform to address a variety of wellness needs.

Since its founding in 1993 in the United States, Mannatech has extended its reach to more than 30 countries across North America, Europe, Asia-Pacific, and Latin America. Headquartered in Flower Mound, Texas, the company maintains regional offices and distribution centers to support its independent sales force. Through ongoing collaborations with academic institutions and research partners, Mannatech invests in clinical studies to validate the efficacy and safety of its products, reinforcing its commitment to science-backed innovation.

Leadership at Mannatech is led by President and Chief Executive Officer Roy Wezelman, who brings extensive experience in direct selling and international operations. The company is guided by a board of directors with backgrounds in nutrition science, regulatory affairs, and global business development. Mannatech continues to pursue growth by expanding its product pipeline, enhancing digital platforms for associate training, and entering new markets where demand for nutritional products is on the rise.

View Mannatech Profile

More Earnings Resources from MarketBeat